Estimates Revisions Egetis Therapeutics AB
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 7.870 SEK | -1.13% |
|
+2.88% | +47.38% |
| 09-14 | Lannebo Hälsa och Ny Teknik rose 5.9% in August, Bico among the month's winners | FW |
| 08-31 | Eight stocks have so far today posted new 52-week highs on the Stockholm Stock Exchange | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- EGTX Stock
- Consensus Egetis Therapeutics AB
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
